Theralase Technologies Inc. V.TLT

Hold period

[DJDawg]

I wasn't sure but found a few links.

There is no hold period on the new shares. So, the price will likely drop today to 0.22 or less.

Once they announce closure then there will be an extra 16 to 24 million shares out there for which they have been bought at a cost of 0.22. Which means that the price will have a hard time moving much above that since the Research Capital Shares will be intermittently sold be people who are happy to just keep the 0.28 warrant.

So in my opinion, for November, the price will stay around 0.22 to 0.25. Anytime it goes much higher so lump asks will appear and likely knock it down.

The only thing that will break 0.28 will be BTD announcement.

Anyone disagree with my logic?

[N0taP00p]

Makes sense to me, DJDawg.  It'll be a miracle at this point if they get BTD any earlier than mid Q1. So this raise has to sustain them for 3-4 months at least. The stock will be in a rut till them because of the added bloat. Er, I mean float. 

[BudFoxx2020]

You are starting to get it.  RC is not here for the science, they are here for the quick buck.  It is an easy sell to their clients.  Let me draw up a scenario.  And Action.  "Hey, Its ???? from Research, how are you today, I got a great investment for you.  TLT, they are curing cancer.  Only 0.22 cents, but here is the bonus.  Every shares you buy you

[DJDawg]

Sadly that all sounds about right. RC will find 5 million dollars to infuse into TLT which will keep the lights on. Everyone who was here or has been here couldn't sell if then wanted to as there are not enough new buyers other than RC. So we are all longholders. Thank god for the science part of it which give me a bit of confidence for the long haul vs the management which give me low

[StevenBirch]

I don't think that those involved in the financing are exactly deadbeats who don't have the money to hold their shares especially with the possibility of BTD being granted at any time. I agree there will be some selling but I think to induce others to sell although may just want the free warrant. I also think the outlook hasn't changed, it was always going to be BTD that moved the

[enriquesuave]

Most of the buyers of this raise will probably hold till research capital SP target of 80 cents. IMHO. Compare to any biotech out there with our data and MC should be way higher.  So some will sell to lock capital and keep warrants, but since the data is amazing and potential catalysts very near, it would be stupid to not take advantage of selling at much higher SP.  

[Rumpl3StiltSkin]

I think that sounds fine. Remember though, volume should increase by many multiples after BTD or JV or AA announcement. Should eat though these extra shares quick. I still think BTD could happen in Q4.

[2b7f6fab]

As a long suffering shareholder I feel whats done is done.  If BTD occurs in December the 50 cent warrants expiring January should be in the money bringing iin another $2 million.